AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor
- PMID: 1567395
- DOI: 10.1016/s0006-291x(05)80313-4
AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor
Abstract
PCR cloning and cDNA sequencing have been used to identify mRNAs of two splice products of the vascular endothelial growth factor (VEGF) gene, VEGF121 and VEGF165, in cells isolated from Kaposi's sarcomas (KS) of AIDS patients (AIDS-KS). As demonstrated by Northern blot analysis, AIDS-KS cells as well as tumor cells show a high expression level of the VEGF gene as compared to primary human vascular cells like smooth muscle cells or endothelial cells. In addition to the lower expression of the gene, vascular cells express a 3.9 kb band together with a 3.2 kb band instead of a 3.9 kb and a 4.3 kb band in AIDS-KS cells. Our data suggest that the angiogenic properties of AIDS-KS cells might be mediated by the secretion of this growth factor and that this factor alone or in combination with other endothelial mitogens may be involved in endothelial proliferation associated with Kaposi's sarcoma.
Similar articles
-
Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma.Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):979-84. doi: 10.1073/pnas.94.3.979. Proc Natl Acad Sci U S A. 1997. PMID: 9023368 Free PMC article.
-
Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma.Am J Pathol. 1996 Dec;149(6):1851-69. Am J Pathol. 1996. PMID: 8952523 Free PMC article.
-
Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells.J Immunol. 1997 May 15;158(10):4992-5001. J Immunol. 1997. PMID: 9144519
-
The role of vascular endothelial growth factor (VEGF) in AIDS-related Kaposi's sarcoma.Oncologist. 2000;5 Suppl 1:28-31. doi: 10.1634/theoncologist.5-suppl_1-28. Oncologist. 2000. PMID: 10804088 Review.
-
Kaposi's sarcoma: its 'oncogenes' and growth factors.Crit Rev Oncol Hematol. 1991;11(2):87-107. doi: 10.1016/1040-8428(91)90001-s. Crit Rev Oncol Hematol. 1991. PMID: 1657029 Review.
Cited by
-
Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.Am J Pathol. 1996 Apr;148(4):1065-74. Am J Pathol. 1996. PMID: 8644848 Free PMC article.
-
The genesis of peritumoral vasogenic brain edema and tumor cysts: a hypothetical role for tumor-derived vascular permeability factor.Yale J Biol Med. 1993 Jul-Aug;66(4):277-314. Yale J Biol Med. 1993. PMID: 7516104 Free PMC article. Review.
-
Treatment of Kaposi's sarcoma. Current guidelines and future perspectives.Drugs. 1994 Oct;48(4):569-82. doi: 10.2165/00003495-199448040-00006. Drugs. 1994. PMID: 7528130 Review.
-
Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects.J Mol Med (Berl). 1995 Jul;73(7):333-46. doi: 10.1007/BF00192885. J Mol Med (Berl). 1995. PMID: 8520966 Review.
-
Biphasic regulation of HMG-CoA reductase expression and activity during wound healing and its functional role in the control of keratinocyte angiogenic and proliferative responses.J Biol Chem. 2008 May 30;283(22):15479-90. doi: 10.1074/jbc.M709841200. Epub 2008 Apr 3. J Biol Chem. 2008. PMID: 18390541 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials